Oncology
Flowchart Overview
 
1
2
2
3
1
1
2
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
NEOGENE-NT-175-201 Phase I OPEN TO ACCRUAL
4
4
1
9
CARIBOU-CAMMOUFLAGE-CB-011A-MM Phase I OPEN TO ACCRUAL
CELGENE-GC-LTFU-001 Phase II/III OPEN TO ACCRUAL
GRACELL-GC012F-CD19-BCMA-001 Phase I/II OPEN TO ACCRUAL
GSK-3377794-LTFU Phase I OPEN TO ACCRUAL
IIT-SHAH-IL7-IL15-CD20-19 Phase I/II OPEN TO ACCRUAL
JNJ-MY4002-CARTINUE-LTFU Phase IV OPEN TO ACCRUAL
JUNO-017004-TRANSCEND-CLL Phase I/II OPEN TO ACCRUAL
NEOGENE-NT-112-301 Phase I OPEN TO ACCRUAL
NEOGENE-NT-175-201 Phase I OPEN TO ACCRUAL
1
TRANSTHERA-TT420C2308 Phase III OPEN TO ACCRUAL
1
2
2
3
2
3
1
1
1
2
5
3
2
2
3
2
3
2
2
2
2
1
NEOGENE-NT-112-301 Phase I OPEN TO ACCRUAL
1
2
1
2
2
2
3
3
1
1
4
1
1
2
2
1
1
2
3
1
4
7
1
1
1
NEOGENE-NT-175-201 Phase I OPEN TO ACCRUAL
4
5
1
1
4
6
1
1
1
1
8
ECOG-EA4232 Phase III OPEN TO ACCRUAL
ICHNOS-ISB-2001-101 Phase I OPEN TO ACCRUAL
IIT-AKHTAR-CILTA-TALQ Phase I OPEN TO ACCRUAL
INCYTE-INCA-34176-254 Phase II OPEN TO ACCRUAL
LILLY-J2N-MC-JZNY Phase IV OPEN TO ACCRUAL
MODERNA-MRNA-2808-P101 Phase I/II OPEN TO ACCRUAL
SWOG-MM1OA-S03 Phase II OPEN TO ACCRUAL
SWOG-MM1YA-S01 Phase II OPEN TO ACCRUAL
20
2
4
2
3
9
3
5
2
4
4
2
1
1
2
1
1
14
4
9
3
2
1
6
1
3
5
4
3
3
3
1
2
2
13
3
2
2
3
4
2
1
POLARIS-2022-001-ARGSARC Phase III OPEN TO ACCRUAL
1
2
3
2
1
1
2
2
1
3
AZ-D516NC00001-TROPION-LUNG14 Phase III OPEN TO ACCRUAL *
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
NEOGENE-NT-112-301 Phase I OPEN TO ACCRUAL
3
7
1
1
1
2
9
5
1
3
CARNABIOSCIENCES-C1763102 Phase I OPEN TO ACCRUAL
ICHNOS-ISB-2001-101 Phase I OPEN TO ACCRUAL
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
12
11
4
2
2
1
1
2
4
3
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
2
2
1
1
6
3
3
1
1
1
1
2
1
1
4
1
2
4
7
5
6
6
2
2
10
1
7
1
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
1
ALLIANCE-A151804 Phase N/A OPEN TO ACCRUAL